Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
21
pubmed:dateCreated
2007-5-23
pubmed:abstractText
The three deleted in liver cancer genes (DLC1-3) encode Rho-GTPase-activating proteins (RhoGAPs) whose expression is frequently down-regulated or silenced in a variety of human malignancies. The RhoGAP activity is required for full DLC-dependent tumor suppressor activity. Here we report that DLC1 and DLC3 bind to human tensin1 and its chicken homolog. The binding has been mapped to the tensin Src homology 2 (SH2) and phosphotyrosine binding (PTB) domains at the C terminus of tensin proteins. Distinct DLC1 sequences are required for SH2 and PTB binding. DCL binding to both domains is constitutive under basal conditions. The SH2 binding depends on a tyrosine in DCL1 (Y442) but is phosphotyrosine-independent, a highly unusual feature for SH2 binding. DLC1 competed with the binding of other proteins to the tensin C terminus, including beta 3-integrin binding to the PTB domain. Point mutation of a critical tyrosine residue (Y442F) in DLC1 rendered the protein deficient for binding the tensin SH2 domain and binding full-length tensin. The Y442F protein was diffusely cytoplasmic, in contrast to the localization of wild-type DLC1 to focal adhesions, but it retained the ability to reduce the intracellular levels of Rho-GTP. The Y442F mutant displayed markedly reduced biological activity, as did a mutant that was RhoGAP-deficient. The results suggest that DLC1 is a multifunctional protein whose biological activity depends on cooperation between its tensin binding and RhoGAP activities, although neither activity depends on the other.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-10783236, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-11823424, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-12495434, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-12531887, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-12606711, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-14647417, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-14674764, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-14694107, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-14723705, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-14999150, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-14999155, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-15273989, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-15286780, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-15506980, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-15567406, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-15680235, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-15892119, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-16024604, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-16204057, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-16489177, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-16493427, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-16533763, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-16774933, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-16862168, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-16951145, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-17016643, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-17190795, http://linkedlifedata.com/resource/pubmed/commentcorrection/17517630-9605766
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
22
pubmed:volume
104
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
9012-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities.
pubmed:affiliation
Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Intramural